Pfizer sued over Lipitor marketing
Pharma Compliance Alert, January 2, 2008
Pfizer's former director of outcomes management strategies claimed Pfizer promoted sales of Lipitor by using a misleading educational campaign for physicians in a lawsuit filed in U.S. District Court for the Eastern District of New York in February 2004, the Wall Street Journal reported.
According to the suit, Pfizer's educational campaign led to physicians prescribing Lipitor to patients who did not need it.
The suit claims Pfizer paid companies to run the Lipitor educational programs through unrestricted educational grants. The suit claims those programs also included deliberate misinformation that promoted Lipitor for use by patients with kidney disease.
The case was originally filed under seal to allow the federal government to intervene. The government chose not to do so and the seal was lifted.
The suit is not the first filed against Pfizer in conjunction with Lipitor. In 2005, a class action lawsuit was filed against Pfizer for allegedly marketing Lipitor to women and the elderly without proof Lipitor reduced the risk of heart attack in those groups.
Click here to read more in the Wall Street Journal.
Comments
0 comments on “Pfizer sued over Lipitor marketing ”
Related Products
-
ePharm5 InDepth
EPharm5 e-mail newsletter delivers the top 5 developments in pharma business innovation, with original research, interviews...
-
Big Pharma Performance Before, During and Beyond the Global Recession
This report assesses the performance of the leading 15 pharmaceutical companies up to, during and beyond the recent global...
Most Popular
- Articles
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- Topic: CMS, OESS post new security compliance review information, checklist
- Capturing all necessary codes for IUD insertion and removal can be challenging
- What does case-mix index mean to you?
- QA:Coding multiple initial infusions
- News and briefs: Oklahoma Osteopathic Association against residency bill change
- HIPAA Q&A: Level of encryption needed for email
- OB services: Coding inside and outside of the package
- E-mailed
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- New conflicts of interest create new challenges
- Q/A. One injection code or two?
- What does case-mix index mean to you?
- ED-to-inpatient transfers are flawed with safety gaps
- Joint Commission Center announces handoff communication solutions
- Inside best practice: Reduce patient falls with a stoplight
- Identify modifiable risk factors to prevent patient falls
- Searched